Low molecular weight chitooligosaccharide inhibits infection of SARS-CoV-2 in vitro.

Donghwan Jang Da-Gyum Lee Young Chul Shin Joong Su Lee Jihee Jung Sung-Weon Ryoo

Published in: Journal of applied microbiology (2022)

In this study, it was suggested for the first time that chitosan-based substances such as chitooligosaccharide can have an antiviral effect on SARS-CoV-2 in vitro.

Keyphrases

sars cov
respiratory syndrome coronavirus
drug delivery
hyaluronic acid